Lorillard
Draft Suggestion for C.T.R. Role
Fields
- Alias
- 03662831/03662836
- Type
- REPT, OTHER REPORT
- ORCH, ORGANIZATIONAL CHART
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Request
- R1-004
- R1-037
- R1-039
- R1-129
- R1-132
- R1-134
- Copied
- Stevens, A.J.
- Date Loaded
- 05 Jun 1998
- Named Organization
- Ad Hoc Comm
- Channing Lab
- Ctr, Council for Tobacco Research
- Harvard Univ
- Sab
- Litigation
- Stmn/Produced
- Characteristic
- DRFT, DRAFT
- MARG, MARGINALIA
- Master ID
- 03662523/3441
- 03662523 Tobacco Industry Council for Tobacco Research Usa -- Research Matters Vol. 2 - 710000
- 03662524-2525
- 03662526
- 03662527 Untitled Document 03662527
- 03662528-2531 Current Status of Ctr's Consideration of Microbiological Associates Contract Proposals
- 03662532-2538 Ctr-Supported Researches: 770000
- 03662539-2545 Expenditures Against 770000 Budget and Estimate for 780000
- 03662546-2547 Untitled Document 03662546/2547
- 03662548-2554 the Rationale for Nicotine or Smoking Studies in Relation to the Central Nervous System (Cns).
- 03662555-2557 Summary of Ctr Meeting 771122
- 03662558 Research Information Review 771122
- 03662559-2566 Prospectives for Ctr in Relation to Cns Studies
- 03662567
- 03662568
- 03662569-2571
- 03662573-2575
- 03662576
- 03662577-2578 Untitled Document 03662577/2578
- 03662579-2580 Bap Experiments
- 03662582-2583
- 03662584-2585
- 03662587-2588
- 03662589
- 03662590-2592 14 New Studies Funded by Tobacco Research Council
- 03662593-2594
- 03662595
- 03662597-2598
- 03662599-2600 Ctr Meeting - 750514 - 750515 (Your Memo of 750416)
- 03662601
- 03662602
- 03662603
- 03662606 Untitled Document 03662606
- 03662607 Notice of Special Meeting of the Board of Directors to Be Held 741205
- 03662608-2609
- 03662610
- 03662611-2612
- 03662613
- 03662613A Professor Is Awarded Leaf Grant
- 03662613B
- 03662614-2615 the Cancer Newsletter
- 03662616-2618 Tobacco Research Group Announces New Studies
- 03662619-2621 Massive Cancer Study Using Made-to-Order Mice
- 03662622-2626 Ctr Report Meeting 740522
- 03662627 Grants and Contracts Meeting 740522
- 03662633-2643 Staff Report Oak Ridge National Laboratories
- 03662644-2645 Noted Pathologist Joins Scientific Advisory Board
- 03662646
- 03662647-2648
- 03662649
- 03662650
- 03662653
- 03662654-2655
- 03662656
- 03662657-2659
- 03662660
- 03662662
- 03662663-2664
- 03662665
- 03662666-2669
- 03662670-2673 Chronology of Events
- 03662674 Untitled Document 03662674
- 03662675-2676 Untitled Document 03662675/2676
- 03662678
- 03662679 Dup of Id 03662665
- 03662680-2683
- 03662684-2687 Chronology of Events
- 03662689
- 03662690-2691
- 03662692
- 03662693
- 03662694
- 03662695-2696
- 03662697
- 03662698
- 03662699
- 03662700
- 03662701-2702 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research
- 03662703 Gaps in Knowledge
- 03662704-2717 Sub-Committee Report
- 03662718-2728 Tobacco and Health Research Some Proposed
- 03662729-2730
- 03662731 C.T.R. - S.A.B.
- 03662732
- 03662733-2737 Meeting of Scientific Advisory Board of the Council for Tobacco Research 730314 New York, N.Y.
- 03662738
- 03662739
- 03662740
- 03662741 Your Reference: 527/111
- 03662742-2743
- 03662744-2746 Progress in Tobacco Health Research Achieved: Machines That Simulate Human Smoking
- 03662747-2748
- 03662749-2751 New Smoking Health Studies Boost Total to $23-Million
- 03662752
- 03662754
- 03662757
- 03662758-2761 Minutes of the Meeting of the Board of Directors 721110
- 03662762-2765 Summary on Work Sponsored by the Council for Tobacco Research on the Effect of Nicotine and Smoking on the Cardiovascular System
- 03662766-2768 Research Program Summary (Confidential)
- 03662769 Proposed Resolution Relating to Authority of Scientific Director in Approval of Grants and Contracts for Research to Be Funded Out of Regular Research Budget
- 03662770-2776 Current Status and Progress of the Research Program
- 03662777-2782 Research Program Projection
- 03662802
- 03662803
- 03662804-2808
- 03662809
- 03662810
- 03662811
- 03662813
- 03662814
- 03662815-2820 Memorandum Concerning Proposed Contract with Oak Ridge National Laboratory for Developing Methodology and Evaluating Smoking Devices for Use in Biological Experiments.
- 03662821-2824 Ctr-Lorillard 000815 - at 200 E42
- 03662825-2826
- 03662827-2828
- 03662830
- 03662837
- 03662838 Council for Tobacco Research
- 03662839
- 03662840-2841 Lorillard Proposal with Respect to Long-Range and Specific Planning for Ctr Research Activities
- 03662843
- 03662844-2846
- 03662847-2848
- 03662849-2852 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research
- 03662853
- 03662854
- 03662857-2858 C.T.R.
- 03662859
- 03662860 Your Note of 720320
- 03662861
- 03662864
- 03662865
- 03662866-2867 Lorillard Proposal with Respect to Long-Range and Specific Planning for Ctr Research Activities
- 03662868 22-Year-Old Heart Study Saved After U.S. Fund Cut
- 03662868A
- 03662869
- 03662870
- 03662871-2873 Untitled Document 03662871/2873
- 03662875-2876
- 03662877-2879 New Tobacco-Health Grants Announced, One Helps Revive Framingham Heart Study
- 03662880
- 03662882
- 03662883-2884 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662885-2889 Significant Smoking-Health Findings Covered in Report by Dr. C.C. Little
- 03662890-2901 the Council for Tobacco Research-Usa Inc
- 03662902 Tobacco Industry Council for Tobacco Research - Usa Current Digests
- 03662904-2943 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662944-2969 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662970-2993 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662994-3021 Current Digest - Author's Index
- 03663022-3061 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663062-3099 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663100-3139 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663140-3173 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663174-3211 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663212-3253 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663254-3287 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663288-3333 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663334-3371 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663372-3407 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663408-3441 Current Digest of Scientific Papers Relating to Tobbacco Use
Related Documents:
Document Images
DRAFT SUGGESTION FOR C. T. R', ROLE
In a: previous note we suggested that the CTR program might be framed
within three basic objectives. These were:
1. To define biologically the effects of smoke on the human system.
2. To define the motivational mechanisms of smoking, using
laboratory animal models, as welli as human populat'ions,
3. To conceptualize and', explore other hypotheses relative to the
Smoking and! Health question by epidemiologicaU and other
appropriate studies.
. These three objectives,, though simplistic inidefinition, appear to
enco.rpass the areas which are, of conc..rn to thc tobacco industry.
Recently, the industry has become intereste& in sponsoring research
in the Channing; Laboratories, Harvard University, and to some considerable
extent their program may overlap the program being carried out; under the
auspices of CTR grants. Consequently, in evaluating what' might'be the future
responsibilities ofl CTR, iti is imperative that unprofitable overlap be avoided.
As far as we are aware, Channing proposes to study tlhe effect of smoke on
the lung, having specific reference to emphysema, bronchitis and, later,, lung
cancer. Secondly, they are suggesting that their program then be expanded to
include heart and vascular diseases,
T
14,

- 2 -
C
If our interpretation of the Channing program is correct, then there would'm seem to be l'ittle
justification in CTR continuing to broaden its present program
under Objective (1). Indeed, there is a case for reevaluating the present
commitments so that any dupllicationi is remove& as soon as conveniently
possible. CTR is also coxmmiitted t'o a number of projects which are etiologically
oriented and it is suggested that these should only be continued if they are of
direct and', positive interest to us. This approach seems eminently suitable,
bearing im mind the scope of t'he National Cancer Plan.
Objective (2) is, we thi'nk,, of tremendous importance to the industry and
should represent ai very important and expanding area of research for the CTR.
Objective (3) is again part of the Channing, proposal, as well as being
funded through various studies under the CTR and Ad Hoc committee granting,
programs. It can be argued, however, that most of these studies suffer from
a lack of suffiicient'ly advanced scientific tools in respect of the possible role
tobacco smoke plays. Therefore, until such time as hetter tools are available
it! is suggested'.t'hat Objective (3)~be restricted to what we are committed to now
(including Channing).
Broadly speaking, therefore, a redefined CTR program could be expressed
as fol'lows:. C
CJ
(a) The pursual of those biological and etiological studies which are ~
supportive of the Chann2ng program. Future studies might be ~
(._
11:

.
- 3 -
C
structured so as to provide future input into the Channing research
program.
(b) Expanded program, on motivational and behavioral studies to provide
better understanding of the benefits of! smoking..
Continuation of those epidemiological studies which (1)' supplement
the Channing program, and (ii) , cover areas not' studied by Channing
and which assist the industry.
Given a broadly based program as stated above, the Scientific Director
of CTR', working,with his staff and consultants, would be expected to define
the major "gaps in knowledge" in each of the three areas to which its efforts
are to be directed and to propose specific research projects intend'ed, so~far
as possible, to fill those gaps.
It seems to us that the pursuit of such a CTR program will require some
reorientation, and to achieve this it is imperative thatl the Scientific Director
take the role of'a strong, aggressive scientist and leader. We guess he would
need assistance in the following areas:
Medical' researchi granting ` Supportive of and cornplementary
Biological research contracis tothe Channing program
~
Behaviorali studies contracts
Epidemiological studies contracts

r
C
-4-
IC
To avoid confusion with respect to communicat'ions, jurisdictional
boundaries~ and responsibilities, it would seem essential to, have liaison
(not control) between CTR and Channing - this should be the function of
the Scientific Directors of Channing and CTR'.
Possible Structure of CTR
Working Group
1
Scientific Director <------- ' Consultants
~
Assistant(s) for i i i Assistant(s) for
Medical and Biological ;J Behavior Studies.
Granting and Contraeting --
i--, 2 ------- -____
~ ---- --- I
A ssistant(s) for Clinical
Epidemiological Studies '
L--- - J
Itl will be noted'that what is proposed here substantially alters the
philosophy of CTR' established at its creation and'maintaiiied through its
course to the present. We in effect, propose abandonment of CTR's broad
commitmentl to "the study of the disease entity, "; ini other words, we are
proposing abandoning CTR's interest in the etiology of di'sease as its primary
area of concern. Secondly,, we would abandon the role of' CTT "s~ Scientific
Director and staff as little more than housekeepers to channel applications for
grants to SAB and to channel funds from SAB' to grantees. Under a moree
objecti've-oriented structure, the Scientific Director and staff, with consultants,
I
~ don=
~
`_

-5-
would be activists in formulating the overall program, developing the specific
projects in implementation of that program, in finding researchers to carry
out the desired work and to expedite performance. In this respect what we
have loosely termed consultants wouldl, we believe, constitutle a truly "'scientific
advisory boardL " Such a group will be available as experts to the Scientific
Director and his staff; their role should not be financial in any sense since
it would be the responsibiliity of the Scientifilc Director to control the budget
spending.
If the industry is to have a~ properly balanced' overall research program,
conforming to industry needs, it ilss necessary that there be coordination
between the various ef'forts. We would propose that the overall program
coordrinationibe formally done through a committee comprised of': the Scientific
Directors of Channing,and CTR, and industry representatives. Apart from
this group, we further propose t'hatl the industry should agree to informal
communication and~ consultation between the Scientific Directors of Channing,
and CTR.

---
